Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myeloma
(Q79887297)
scientific article published on 01 July 2006
scientific article published on 01 July 2006
Language:
other details
| description | scientific article published on 01 July 2006 |
External Links
| (P356) |
10.4065/81.7.889
|
| (P698) |
16835968
|